Literature DB >> 22143557

Peripunctal melanocytic nevus.

Cindy S Hwang1, Seongmu Lee, Michael T Yen.   

Abstract

We report a case of a 37-year-old male with a conjunctival melanocytic nevus presenting in a rare, peripunctal location with preservation of the lacrimal canaliculus and punctum.

Entities:  

Mesh:

Year:  2011        PMID: 22143557     DOI: 10.1007/s10792-011-9485-1

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Peripunctal melanocytic nevi. Distinctive clinical findings and differential diagnosis.

Authors:  K R Scott; F A Jakobiec; R L Font
Journal:  Ophthalmology       Date:  1989-07       Impact factor: 12.079

2.  The clinicopathological spectrum of benign peripunctal tumours.

Authors:  Shimon Rumelt; Jacob Pe'er; Peter A D Rubin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-19       Impact factor: 3.117

3.  Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors.

Authors:  Carol L Shields; Hakan Demirci; Ekaterina Karatza; Jerry A Shields
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

4.  Conjunctival nevi: clinical features and natural course in 410 consecutive patients.

Authors:  Carol L Shields; Airaj F Fasiuddin; Airey Fasiudden; Arman Mashayekhi; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2004-02

5.  Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.

Authors:  Gustavo A Novais; Bruno F Fernandes; Rubens N Belfort; Enzo Castiglione; Devinder P Cheema; Miguel N Burnier
Journal:  Int J Surg Pathol       Date:  2008-07-08       Impact factor: 1.271

Review 6.  Tumors of the conjunctiva and cornea.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Surv Ophthalmol       Date:  2004 Jan-Feb       Impact factor: 6.048

  6 in total
  1 in total

1.  [Prolapse of the upper lacrimal punctum].

Authors:  F Bucher; J W U Fries; D Hos; K R Koch; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.